Not applicableStudy completedNCT05313529
What this trial is testing
LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes
Who this might be right for
Type 2 Diabetes MellitusMild Cognitive Impairment
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 396